ストックスクリーナーアプリを入手
5.47
0.18%
0.010
前日終値:
$5.46
開ける：
$5.47
24時間の取引高:
458.13K
Relative Volume:
0.38
時価総額：
$1.23B
収益：
$596.48M
当期純損益:
$123.72M
株価収益率:
9.9745
EPS:
0.5484
ネットキャッシュフロー:
$106.59M
1週間 パフォーマンス:
+1.11%
1か月 パフォーマンス:
+0.37%
6か月 パフォーマンス:
+45.09%
1年 パフォーマンス:
+72.56%
1日の値動き範囲:
$5.45
$5.495
1週間の範囲:
$5.35
$5.495
52週間の値動き範囲:
$2.37
$5.72
Curevac N V Stock (CVAC) Company Profile
CVAC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVAC
Curevac N V
|
5.47 | 1.23B | 596.48M | 123.72M | 106.59M | 0.5484 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 60.58B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 54.99B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
674.90 | 42.25B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.93B | 3.81B | -644.79M | -669.77M | -6.24 |
Curevac N V Stock (CVAC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-13 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-25 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-06-08 | 開始されました | SVB Securities | Outperform |
| 2023-01-19 | アップグレード | UBS | Neutral → Buy |
| 2023-01-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-01-21 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-01-18 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-10-22 | 開始されました | Deutsche Bank | Hold |
| 2021-06-17 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-04-26 | 再開されました | Credit Suisse | Underperform |
| 2021-04-26 | 開始されました | Guggenheim | Neutral |
| 2020-12-10 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2020-09-08 | 開始されました | BofA Securities | Buy |
| 2020-09-08 | 開始されました | Credit Suisse | Neutral |
| 2020-09-08 | 開始されました | Jefferies | Hold |
すべてを表示
Curevac N V (CVAC) 最新ニュース
Will CureVac N.V. stock benefit from AI tech trendsFast Gaining Stock Screener Reports Released - metal.it
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth - Benzinga
How the U.S. mRNA Therapeutics Market Will Evolve by 2032 - openPR.com
BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update - The Manila Times
Is CureVac N.V. a good long term investmentFree Investment Portfolio Suggestions - Jammu Links News
Bullish Candlestick Pattern Forms in CureVac N.V.AI Based High Gain Watchlist Scanner Shared - beatles.ru
What is CureVac N.V. company’s growth strategyMassive wealth growth - Jammu Links News
Should I hold or sell CureVac N.V. stock in 2025Superior portfolio returns - Jammu Links News
What makes CureVac N.V. stock price move sharplyHigh-return market picks - Jammu Links News
When is CureVac N.V. stock expected to show significant growthGet expert advice on portfolio optimization - Jammu Links News
CureVac N.V. Stock Analysis and ForecastMaximize gains with data-driven stock picks - Jammu Links News
How volatile is CureVac N.V. stock compared to the marketStay ahead with daily market updates - Jammu Links News
Does CureVac N.V. stock perform well during market downturnsGet daily expert analysis for smarter investing - Jammu Links News
What are analysts’ price targets for CureVac N.V. in the next 12 monthsUnlock daily stock market insights for success - Jammu Links News
Is it the right time to buy CureVac N.V. stockSignificant capital appreciation - Jammu Links News
How strong is CureVac N.V. company’s balance sheetRetirement Planning Signals To Watch Now - jammulinksnews.com
Is CureVac N.V. stock overvalued or undervaluedReal Time Signals For Consistent Profits - Jammu Links News
Why CureVac N.V. stock attracts strong analyst attentionPattern Detection for Entry Confirmation Enabled - beatles.ru
Short Covering May Lift CureVac N.V. in Near TermRisk Adjusted Technical Entry Plan Gains Followers - metal.it
CureVac N.V.Finanzen.net - Finanzen.net
Traders Consider Averaging Down in CureVac N.V.Smart Investment Tips Gaining Popularity Among Analysts - metal.it
How does CureVac N.V. generate profit in a changing economyTremendous wealth creation - Jammu Links News
Why is CureVac N.V. stock attracting strong analyst attentionMaximize returns with expert trading insights - Jammu Links News
What is the dividend policy of CureVac N.V. stockBuild a balanced portfolio for long-term success - Jammu Links News
What drives CureVac N.V. stock priceExplosive trading opportunities - PrintWeekIndia
Will CureVac N.V. stock benefit from interest rate changesFree Stock Market Real-Time Monitoring - Jammu Links News
DekaBank Deutsche Girozentrale Buys Shares of 1,941 CureVac (NASDAQ:CVAC) - 富途牛牛
What analysts say about CureVac N.V. stockExponential return rates - Autocar Professional
Curevac N V (CVAC) 財務データ
収益
当期純利益
現金流量
EPS
0.40%
0.08%
大文字化:
|
ボリューム (24 時間):